Advisory Research Inc Tg Therapeutics, Inc. Transaction History

Advisory Research Inc

  • $512 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 12, 2021
SELL
$25.27 - $54.9 $826,986 - $1.8 Million
-32,726 Closed
0 $0
Q3 2020

Nov 12, 2020
BUY
$18.49 - $27.24 $238,890 - $351,940
12,920 Added 65.23%
32,726 $876,000
Q2 2020

Aug 13, 2020
BUY
$8.9 - $21.84 $176,273 - $432,563
19,806 New
19,806 $386,000

Others Institutions Holding TGTX

# of Institutions
338
Shares Held
87.7M
Call Options Held
2.35M
Put Options Held
1.7M
View Full List

About TG THERAPEUTICS, INC.

TGTX Quotes by TradingView
  • Ticker TGTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 145,274,000
  • Market Cap $4.68B
  • Description
  • TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...
More about TGTX
Track This Portfolio

Track Advisory Research Inc Portfolio

Follow Advisory Research Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisory Research Inc, based on Form 13F filings with the SEC.

News

Stay updated on Advisory Research Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email